diallyl trisulfide has been researched along with Colitis Gravis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, Y; Guo, Y; Wei, Z; Xia, Y; Zhang, Q; Zhang, Y; Zhu, Y | 1 |
| Bai, AP; Hu, RW; Ouyang, Q | 1 |
2 other study(ies) available for diallyl trisulfide and Colitis Gravis
| Article | Year |
|---|---|
Diallyl Trisulfide, a Major Bioactive Constituent of Garlic, Promotes Colonic Mucosal Healing in Ulcerative Colitis through Accelerating Focal Adhesion Assembly and Consequent Epithelial Cell Migration via the Rab21-Integrin β1-Fak Pathway.
Topics: Animals; Cell Movement; Colitis; Colitis, Ulcerative; Epithelial Cells; Female; Focal Adhesion Protein-Tyrosine Kinases; Focal Adhesions; Garlic; Integrin beta1; Mice; Mice, Inbred C57BL | 2023 |
Diallyl trisulfide inhibits tumor necrosis factor-alpha expression in inflammed mucosa of ulcerative colitis.
Topics: Adult; Aged; Allyl Compounds; Colitis, Ulcerative; Female; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Intestinal Mucosa; L-Lactate Dehydrogenase; Male; Middle Aged; NF-kappa B; RNA, Messenger; Sulfides; Tumor Necrosis Factor-alpha | 2005 |